A year later, House Speaker Mike Johnson tapped two of his most right-wing members for the committee, generating bipartisan pushback. When the Louisiana Republican was pressed for an explanation ...

Bryan Johnson, a tech entrepreneur, has stopped using rapamycin, a drug not approved for anti-aging by the FDA, following concerns it may have aged him and caused infections. Johnson experienced ...

NASCAR Hall of Famer Jimmie Johnson will attempt to qualify for the 2025 Daytona 500 (Feb. 16, 2:30 p.m. ET, FOX, MRN Radio, SiriusXM NASCAR Radio), the seven-time NASCAR Cup Series champion annou ...

The Ravens' surprising waiver claim for journeyman Diontae Johnson could result in an additional draft pick for Baltimore. Johnson, who was waived by Baltimore earlier this season, was claimed by ...

The Diontae Johnson experiment is over in Houston. The Texans announced Tuesday they had waived the former Pro Bowl wideout ahead of their divisional-round matchup vs. the Kansas City Chiefs.

Diontae Johnson has been claimed on waivers by the Baltimore Ravens one day after he parted ways with the Houston Texans, according to ESPN's Adam Schefter. Johnson joined the Texans on Dec. 26 ...

Per ESPN's Adam Schefter, the Ravens claimed Diontae Johnson off waivers from the Houston Texans to potentially give the team a comp pick in 2026. Adam Schefter @AdamSchefter Back to Baltimore ...

Rep. Thomas Massie, one of the most outspoken critics of House Speaker Mike Johnson, is off the powerful House Rules Committee, which plays a critical role in the functioning of the lower chamber ...

Diontae Johnson's 2024 odyssey has reached another twist. The Texans waived Johnson on Tuesday, the team announced. "With Diontae, unfortunately it didn't work out and we're on to the Chiefs ...

Magic Johnson is on another playoff run. Now Johnson is experiencing the NFL postseason for the first time as a minority owner of the Washington Commanders, a team that has a storied NFL history ...

Johnson & Johnson (NYSE:JNJ) announced a $14.6 billion acquisition of Intra-Cellular Therapies, Inc. (NASDAQ:ITCI) ahead of this week’s JP Morgan Healthcare Conference. Shares of Intra-Cellular ...

Mario Tama / Getty Images Shares of Intra-Cellular Therapies jumped Monday morning after Johnson & Johnson announced plans to buy the biopharmaceutical company. Intra-Cellular shareholders will ...